These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6115301)

  • 21. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL; Kastin AJ; Beilstein BA; Vento AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
    Voith K
    Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tyr-MIF-1 family of peptides.
    Reed GW; Olson GA; Olson RD
    Neurosci Biobehav Rev; 1994; 18(4):519-25. PubMed ID: 7708364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of MIF-1 and its cyclic derivative alaptide on agonistic behaviour in mice.
    Sulcová A; Krejcí I
    Homeost Health Dis; 1991; 33(4):167-8. PubMed ID: 1687863
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
    Costain WJ; Buckley AT; Evans MC; Mishra RK; Johnson RL
    Peptides; 1999; 20(6):761-7. PubMed ID: 10477133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cyclic peptide (Pro-Leu-Gly)2 on calcium signaling in isolated myometrial cells from pregnant rat.
    Kaneko Y; Shojo H; Uchimura T
    Pharmacol Toxicol; 2001 Nov; 89(5):277-80. PubMed ID: 11881983
    [No Abstract]   [Full Text] [Related]  

  • 27. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol.
    Szabó G; Kovács GL; Székeli S; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1987; 69(1):115-22. PubMed ID: 2884803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
    Björkman S; Lewander T; Zetterström T
    J Pharm Pharmacol; 1980 Apr; 32(4):296-7. PubMed ID: 6103063
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of a spirocyclic cyclodipeptide derivate of MIF on passive avoidance behavior and amnesia in rats.
    Krejcí I; Dlabac A; Vanzura J; Kosnar J
    Act Nerv Super (Praha); 1986 Dec; 28(4):241-6. PubMed ID: 2881422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
    Pugsley TA; Lippmann W
    Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The lateralized effects of the melanostatin analog alaptide in rats raised in isolation and in a community].
    Lebedev AA; Shabanov PD; Chepurnova NE; Paskhali E; Krejcí I; Kasafírek E
    Fiziol Zh Im I M Sechenova; 1994 Oct; 80(10):24-31. PubMed ID: 7536538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors.
    Gulati A; Bhargava HN
    Pharmacology; 1990; 41(2):98-106. PubMed ID: 1979878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of oxytocin and fragment (MIF-I) on the development of tolerance to hypothermic and hypnotic action of ethanol in the rat.
    Puciłowski O; Kostowski W; Trzaskowska E
    Peptides; 1985; 6(1):7-10. PubMed ID: 2859573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Tyr-MIF-1 peptides on blood ACTH and corticosterone concentration induced by three experimental models of stress.
    Bocheva A; Dzambazova E; Hadjiolova R; Traikov L; Mincheva R; Bivolarski I
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):117-23. PubMed ID: 18798907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of haloperidol catalepsy.
    Ezrin-Waters C; Seeman P
    Eur J Pharmacol; 1977 Feb; 41(3):321-7. PubMed ID: 556989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Bhargava HN; Pandey RN; Matwyshyn GA
    Life Sci; 1983 May; 32(18):2096-101. PubMed ID: 6133201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia?
    Bhargava HN
    Mod Probl Pharmacopsychiatry; 1983; 21():196-205. PubMed ID: 6656783
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.